The urgent need for the development of early tumor diagnosis and effective anti-tumor therapies remains. This work intends to provide a relatively broad audience with a novel approach for the development of cancer diagnostics and targeted therapeutics, based on recently proved hypotheses. It provides coverage of the most important aspects of a selected domain of tumor immunology, namely the characteristics and potential capacity of the tumor infiltrating B lymphocytes.
The book will provide a relatively broad audience with a novel approach for the development of cancer diagnostics and targeted therapeutics, based on recently proved hypotheses.
The book will provide comprehensive coverage of the most important aspects of a selected domain of tumor immunology -- the characteristics and potential capacity of the tumor infiltrating B lymphocytes.
The book will focus on the identification of novel tumor antigens that would be potential targets for tumor diagnostics and therapeutics.
The book was written by an expert in the field.
Introduces the readers to the highly interesting matter of therapeutic drug discovery, based on a great variety of possibilities in antibody engineering and biotechnology
Researchers, clinicians, medical students (and eventually some patients with interest) will be guided through this exiting methodological pathway. By supplying the readers with recent results concerning the feasibility of the whole process, it will give them hope that cancer might someday be detected and cured within a reasonable time
Beatrix Kotlan
B lymphocytes anti-tumor therapies early diagnosis therapeutics tumor antig tumor diagnostics tumor immunology